R92 Kategorie · weitere Spezifizierung erforderlich Abnormal and inconclusive findings on diagnostic imaging of breast
ICD-10-CM R92 identifies “Abnormal and inconclusive findings on diagnostic imaging of breast” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Kapitel 18: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Hinweise zum Code
Keine zusätzlichen Hinweise.
Hinweise übergeordneter Ebenen
Kapitel 18 · Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R99)
Excludes 24
Note9
- This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions regarding which no diagnosis classifiable elsewhere is recorded.
- Signs and symptoms that point rather definitely to a given diagnosis have been assigned to a category in other chapters of the classification. In general, categories in this chapter include the less well-defined conditions and symptoms that, without the necessary study of the case to establish a final diagnosis, point perhaps equally to two or more diseases or to two or more systems of the body. Practically all categories in the chapter could be designated 'not otherwise specified', 'unknown etiology' or 'transient'. The Alphabetical Index should be consulted to determine which symptoms and signs are to be allocated here and which to other chapters. The residual subcategories, numbered .8, are generally provided for other relevant symptoms that cannot be allocated elsewhere in the classification.
- The conditions and signs or symptoms included in categories R00-R94 consist of:
- (a) cases for which no more specific diagnosis can be made even after all the facts bearing on the case have been investigated;
- (b) signs or symptoms existing at the time of initial encounter that proved to be transient and whose causes could not be determined;
- (c) provisional diagnosis in a patient who failed to return for further investigation or care;
- (d) cases referred elsewhere for investigation or treatment before the diagnosis was made;
- (e) cases in which a more precise diagnosis was not available for any other reason;
- (f) certain symptoms, for which supplementary information is provided, that represent important problems in medical care in their own right.
R90-R94 · Abnormal findings on diagnostic imaging and in function studies, without diagnosis (R90-R94)
Includes6
- nonspecific abnormal findings on diagnostic imaging by computerized axial tomography [CAT scan]
- nonspecific abnormal findings on diagnostic imaging by magnetic resonance imaging [MRI][NMR]
- nonspecific abnormal findings on diagnostic imaging by positron emission tomography [PET scan]
- nonspecific abnormal findings on diagnostic imaging by thermography
- nonspecific abnormal findings on diagnostic imaging by ultrasound [echogram]
- nonspecific abnormal findings on diagnostic imaging by X-ray examination
Excludes 12
- abnormal findings on antenatal screening of mother (O28.-)
- diagnostic abnormal findings classified elsewhere - see Alphabetical Index
Spezifischere Codes
R92.0Mammographic microcalcification found on diagnostic imaging of breastAbrechenbarer, spezifischer CodeR92.1Mammographic calcification found on diagnostic imaging of breastAbrechenbarer, spezifischer CodeR92.2Inconclusive mammogramAbrechenbarer, spezifischer CodeR92.3Mammographic density found on imaging of breastKategorie · weitere Spezifizierung erforderlichR92.8Other abnormal and inconclusive findings on diagnostic imaging of breastAbrechenbarer, spezifischer CodeVerweise im offiziellen Index
Verweise anderer Codes (1)
Excludes 2 · abnormal findings on diagnostic imaging of breast (R92.-)
Verlauf
Codeverlauf
Keine Änderung seit der ersten Erfassung
GeändertUnverändert
FY2016
Gültig ab
- Erstmals erfasst
Abnormal and inconclusive findings on diagnostic imaging of breast
Kategorie — spezifischeren Code auswählen
CDC/NCHS · FY2016Alle Ausgaben (19)
| Alle Ausgaben | Gültig ab | Codeverlauf |
|---|---|---|
| FY2016 | 2015-10-01 | Erstmals erfasst |
| FY2017 | 2016-10-01 | Keine tabellarische Änderung |
| FY2018 | 2017-10-01 | Keine tabellarische Änderung |
| FY2019 | 2018-10-01 | Keine tabellarische Änderung |
| FY2020 | 2019-10-01 | Keine tabellarische Änderung |
| FY2020 · April | 2020-04-01 | Keine tabellarische Änderung |
| FY2021 | 2020-10-01 | Keine tabellarische Änderung |
| FY2021 · 01-01 | 2021-01-01 | Keine tabellarische Änderung |
| FY2022 | 2021-10-01 | Keine tabellarische Änderung |
| FY2022 · 04-01 | 2022-04-01 | Keine tabellarische Änderung |
| FY2023 | 2022-10-01 | Keine tabellarische Änderung |
| FY2023 · 04-01 | 2023-04-01 | Keine tabellarische Änderung |
| FY2024 | 2023-10-01 | Keine tabellarische Änderung |
| FY2024 · 04-01 | 2024-04-01 | Keine tabellarische Änderung |
| FY2025 | 2024-10-01 | Keine tabellarische Änderung |
| FY2025 · 04-01 | 2025-04-01 | Keine tabellarische Änderung |
| FY2026 | 2025-10-01 | Keine tabellarische Änderung |
| FY2026 · April | 2026-04-01 | Keine tabellarische Änderung |
| FY2027 | 2026-10-01 | Keine tabellarische Änderung |
Entdecken Sie die spezifischeren Codes dieser Kategorie. Die Referenzprüfung bestätigt keine klinische Eignung und garantiert keine Erstattung.